WHO ICTRP trial
A phase I study of irinotecan for previously treated lung cancer patients with…
JPRN-UMIN000006095 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000006095 |
|---|---|
| Public title | A phase I study of irinotecan for previously treated lung cancer patients with UGT1A1*28 or *6 polymorphism |
| Scientific title | A phase I study of irinotecan for previously treated lung cancer patients with UGT1A1*28 or *6 polymorphism - Irinotecan PI for UGT1A1*28*6 lung cancer |
| Primary sponsor | Lung Oncology Group in Kyusyu, Japan (LOGiK) |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase I |
| Countries | Japan |
| Conditions | lung cancer |
| Interventions | Irinotecan |
| Registration date | Jan 8, 2011 |
| Target size | 15 |
| Registry page | center6.umin.ac.jp |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: